Natixis Advisors, L.P. Novartis Ag Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Novartis Ag stock. As of the latest transaction made, Natixis Advisors, L.P. holds 860,998 shares of NVS stock, worth $113 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
860,998
Previous 871,970
1.26%
Holding current value
$113 Million
Previous $97.2 Million
7.18%
% of portfolio
0.17%
Previous 0.18%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,560Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$994 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$937 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...